|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.775
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.724
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.717
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.541
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.442
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.415
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.405
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.345
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.327
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.295
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.268
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.256
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.251
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.233
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.229
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.176
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.171
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.165
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.164
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.160
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.158
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.156
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.154
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.152
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.140
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.139
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.136
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.135
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.131
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.129
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.125
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.117
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.116
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.113
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.112
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.112
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.106
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.100
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.098
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.095
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.091
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.091
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.079
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.079
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.078
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.078
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.078
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.077
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.076
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.072
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.072
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.071
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.070
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.070
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.067
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.066
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.066
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.063
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.063
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.063
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.062
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.061
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.060
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.060
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.060
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.059
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.059
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.059
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.055
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.055
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.055
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.053
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.053
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.053
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.051
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.051
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.050
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.050
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.050
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.049
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.048
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.048
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.048
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.048
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.047
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.046
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.046
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.046
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.046
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.046
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.046
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.045
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.045
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.045
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.045
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.042
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.042
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.041
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.041
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.041
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.040
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.040
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.040
|
|
|
|
germinal center formation
|
GO:0002467 |
16 |
0.040
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.040
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.040
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.039
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.039
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.039
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.039
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.038
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.038
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.038
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.038
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.037
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.037
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.037
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.036
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.035
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.035
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.035
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.035
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.035
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.035
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.034
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.034
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.034
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.033
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.033
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.033
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.033
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.032
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.032
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.032
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.032
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.031
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.031
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.031
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.031
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.030
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.030
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.030
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.030
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.030
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.030
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.029
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.029
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.028
|
Fly |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.028
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.028
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.028
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.028
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.028
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.027
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.027
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.027
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.026
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.026
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.026
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.026
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.025
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.025
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.025
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.025
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.025
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.025
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.025
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.025
|
|
|
|
histone h4 k20 methylation
|
GO:0034770 |
8 |
0.025
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.025
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.025
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.025
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.025
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.024
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.024
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.024
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.023
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.023
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.023
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.023
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.023
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.023
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.023
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.023
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.023
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.023
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.022
|
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.022
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.022
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.022
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.022
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.022
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.022
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.022
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.022
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.022
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.022
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.022
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.022
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.021
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.021
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.021
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.021
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.021
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.021
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.020
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.020
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.020
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.020
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.020
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.020
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.020
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.020
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.020
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.020
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.019
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.019
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.019
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.019
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.019
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.019
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.019
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.019
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.018
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.018
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.018
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.018
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
Fly |
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.018
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.018
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.018
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.018
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.018
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.018
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.018
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.017
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.017
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.017
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.017
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.017
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.017
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.017
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.017
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.017
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.017
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.017
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.017
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.017
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.017
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.017
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.017
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.017
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.017
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.016
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.016
|
|
|
|
negative regulation of g protein coupled receptor protein signaling pathway
|
GO:0045744 |
12 |
0.016
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.016
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.016
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.016
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.016
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.016
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.015
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.015
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.015
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.015
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.015
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.015
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.015
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.015
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.015
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.015
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.015
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.015
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.015
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.015
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.015
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.015
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.015
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.015
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.015
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.015
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.015
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.015
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.015
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.015
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.014
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.014
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.014
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.014
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.014
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.014
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.014
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.014
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.014
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.014
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.014
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.014
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.014
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.014
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.014
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.013
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.013
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.013
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.013
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.013
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.013
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.013
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.013
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.013
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.013
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.013
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.013
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.013
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.013
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.013
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.013
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.013
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.013
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.013
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.013
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.013
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.013
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.013
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.013
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.013
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.012
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.012
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.012
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.012
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.012
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.012
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.012
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.012
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.012
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.012
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.012
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.012
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.012
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.012
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.012
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.012
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.012
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.012
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.012
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.012
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.012
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.012
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.012
|
Fly |
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.012
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.012
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.012
|
Fly |
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.012
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.012
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.012
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.011
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.011
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.011
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.011
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.011
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.011
|
|
